About Saul
Oxford-educated Neuroscientist with deep subject matter expertise across multiple aspects of Biopharmaceutical supply chain. Extensive knowledge of the dynamics of the contract development & outsourcing sector (competitor landscape, trends, drivers, potential wild cards). Comfortable working remotely in geographically dispersed diverse teams. Emotionally intelligent and conscious of the intangible factors that often drive success.
Demonstrable track record of new drug development and able to span clinical and commercial functions with particular interest in CNS & Auto-Immune disorders.
Will strive to understand client needs beyond remit.
English
Native or bilingual
Remote only
Primarily works remotely
Experience
- UCB BelgiumDirector R&D NeurologyPHARMACEUTICALS INDUSTRYJune 2018 - January 2022 (3 years and 6 months)Slough, United KingdomPartnered Rare Disease business to develop auto-immune portfolio strategy, maximising asset differentiation in a crowded therapy class.Developed a build vs. buy model for AAV Gene Therapy questioning corporate assumptions on cost; recalibrated manufacturing (yield) estimates; timelines, with implications for key decision points in development and commercial strategy.Led review of UCB’s neuroscience strategy, challenging dependency on epilepsy portfolio. Questioned legacy decision-making, identifying protracted governance decisions and poor development timelines.Head of commercial insight into early pipeline asset development for Bepranemab in Alzheimer’s disease; spearheaded competitor intelligence, market landscape and therapy area overview for joint venture with Genentech, with end-to-end analysis for accelerated clinical programme.Partnered Licensing group to explore business development opportunities in epilepsy, accountable for long-term forecasting of epilepsy market and prospects for rare epilepsy acquisitions.Established competitive intelligence for auto-immune and neurodegenerative therapies. Accountable for insight generation including anticipation of competitor strategy (“war games”) and potential counter activities.Challenged existing company structure to compete more effectively with the new generation of highly- capitalised Biopharma, proposing disruptive alternatives in Rare and Ultra Rare Diseases.
- GlobaldataDirector Market IntelligencePHARMACEUTICALS INDUSTRYJune 2012 - June 2018 (6 years)Reading, United KingdomCreator in Chief PharmSource CDMO Industry Intelligence, Consultancy, Strategic Advantage Database, Industry Trend Reports, Lead Sheet Strategy, and Editor.Built the brand equity of PharmSource into a business acquired by AIM Listed GlobalData.Grew Strategic Advantage subscriber base fivefold to over 65 clients and expanded subscriber revenue nine-fold to over $1.2 million in 5 years.Principal consultant to global pharmaceutical contract manufacturers on corporate strategy, manufacturing demand, and competitor positioning. Advisor on market entry strategy to GSK on contract manufacturing; consultant to top 5 US contract manufacturers on M&A targets.
- Abbott Laboratories (UK)Business Support ManagerPHARMACEUTICALS INDUSTRYOctober 2007 - June 2012 (4 years and 8 months)Maidenhead, United KingdomStrategy and Corporate Development, Business Intelligence & Analytics, Sales and MarketingJoint-venture with medical nutritional company, structuring profit-share arrangements.Developed financial metrics to measure entry into high-margin metabolic diseases; acquisition and in-licensing, closing portfolio gaps.
Recommendations
Be the first to recommend Saul
Help this freelancer shine by sharing your experience working together.
These freelancer profiles also match your criteria
Agatha Frydrych
Backend Java Software Engineer
4.7
(3)
2
Baptiste Duhen
Fullstack developer
4.6
(4)
5
Amed Hamou
Senior Lead Developer
4
(2)
7
Audrey Champion
Web developer
4.3
(3)
4
Education
- D.PhilUniversity of Oxford1995Neuropharmacology (characterization of excitatory amino acids in the mammalian central nervous system)
- MScInstitute of Psychiatry1990Neuroscience (modules & research)